JPWO2022114154
A method for detecting mild cognitive impairment and/or mild Alzheimer's disease, includes measuring the amount or concentration of a biomolecule in a biological sample from a test subject. The biomolecule is one or more proteins selected from FGF-19, PLA2G10 and CPA2. In the detection method,...
Saved in:
| Format | Patent |
|---|---|
| Language | Japanese |
| Published |
02.06.2022
|
| Online Access | Get full text |
Cover
| Summary: | A method for detecting mild cognitive impairment and/or mild Alzheimer's disease, includes measuring the amount or concentration of a biomolecule in a biological sample from a test subject. The biomolecule is one or more proteins selected from FGF-19, PLA2G10 and CPA2. In the detection method, it is possible to determine the likelihood of suffering from mild cognitive impairment and/or mild Alzheimer's disease using the amount or concentration of the biomolecule in the biological sample from the test subject as an index. |
|---|---|
| Bibliography: | Application Number: JP20220565471 |